Vascugen

Vascugen is a company specializing in induced pluripotent stem cell (iPSC) therapy, focusing on the development and manufacturing of engineered vascular cells to address ischemic diseases. Their innovative vasculogenic cell technology aims to restore blood flow and function in tissues affected by vascular degenerative conditions. Targeting patients... with critical limb ischemia and diabetic retinopathy, Vascugen seeks to provide regenerative medicine solutions where traditional treatments have failed. The company is also exploring applications in tissue engineering and partnerships to advance their technology in the emerging field of bio-ink for organ fabrication.Read More